Cargando…

Interaction of p-synephrine on the pharmacodynamics and pharmacokinetics of gliclazide in animal models

BACKGROUND: Type 2 diabetes is frequently seen in patients suffering from obesity. p-synephrine and gliclazide are widely used medicines for the treatment of obesity and diabetes, respectively. OBJECTIVES: The present study was undertaken to determine the potential for interactions between p-synephr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vatsavai, Leela Krishna, Kilari, Eswar Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Original Research Article- Experimental
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148059/ https://www.ncbi.nlm.nih.gov/pubmed/29103851 http://dx.doi.org/10.1016/j.jaim.2017.04.010

Ejemplares similares

Influence of curcumin on the pharmacodynamics and pharmacokinetics of gliclazide in animal models
por: Vatsavai, Leela Krishna, et al.
Publicado: (2016)

Influence of aprepitant on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits
por: Kura, Raghunandan Reddy, et al.
Publicado: (2018)

Effect of antiretroviral drugs on the pharmacodynamics of gliclazide with respect to glucose–insulin homeostasis in animal models
por: Mastan, S K, et al.
Publicado: (2009)

Influence of non-nucleoside reverse transcriptase inhibitors (efavirenz and nevirapine) on the pharmacodynamic activity of gliclazide in animal models
por: Mastan, SK, et al.
Publicado: (2009)

Pharmacokinetics and Pharmacodynamics of Gliclazide from Immediate and Modified Release Formulation Tablets in Rats
por: Resztak, M, et al.
Publicado: (2014)

Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Toxicity Study
por: Nazief, Alaa Mohamed, et al.
Publicado: (2020)

p‐Synephrine, ephedrine, p‐octopamine and m‐synephrine: Comparative mechanistic, physiological and pharmacological properties
por: Stohs, Sidney J., et al.
Publicado: (2020)

Pharmacokinetics and Anti-Diabetic Studies of Gliclazide Nanosuspension
por: Sampathi, Sunitha, et al.
Publicado: (2022)

Atazanavir–bilirubin interaction: a pharmacokinetic–pharmacodynamic model
por: Lozano, Roberto, et al.
Publicado: (2013)

Effects of p-Synephrine during Exercise: A Brief Narrative Review
por: Ruiz-Moreno, Carlos, et al.
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics of Clofazimine for Treatment of Cryptosporidiosis
por: Zhang, Cindy X., et al.
Publicado: (2022)

The effects of supplementation with P-Synephrine alone and in combination with caffeine on resistance exercise performance
por: Ratamess, Nicholas A., et al.
Publicado: (2015)

Influence of trazodone on the pharmacodynamics and pharmacokinetics of pioglitazone
por: Pradeepkumar, Bhupalam, et al.
Publicado: (2022)

The Overview on the Pharmacokinetic and Pharmacodynamic Interactions of Triazoles
por: Czyrski, Andrzej, et al.
Publicado: (2021)

Fabrication and Characterization of Gliclazide Nanocrystals
por: Ravouru, Nagaraju, et al.
Publicado: (2018)

Drug–drug Interaction between Pravastatin and Gemfibrozil (Antihyperlipidemic) with Gliclazide (Antidiabetic) in Rats
por: Sultanpur, CM, et al.
Publicado: (2010)

A Review of the Receptor-Binding Properties of p-Synephrine as Related to Its Pharmacological Effects
por: Stohs, Sidney J., et al.
Publicado: (2011)

Pharmacokinetic-Pharmacodynamic Analysis of Spiroindolone Analogs and KAE609 in a Murine Malaria Model
por: Lakshminarayana, Suresh B., et al.
Publicado: (2015)

Atazanavir–bilirubin interaction: a pharmacokinetic–pharmacodynamic model [Corrigendum]
Publicado: (2013)

Pharmacokinetics, Pharmacodynamics and Antiviral Efficacy of the MEK Inhibitor Zapnometinib in Animal Models and in Humans
por: Koch-Heier, Julia, et al.
Publicado: (2022)

Evaluation of pharmacokinetics of warfarin from validated pharmacokinetic-pharmacodynamic model
por: Sridharan, Kannan, et al.
Publicado: (2021)

In Vitro Investigation of Binding Interactions between Albumin–Gliclazide Model and Typical Hypotensive Drugs
por: Zurawska-Plaksej, Ewa, et al.
Publicado: (2021)

Safety, Efficacy, and Mechanistic Studies Regarding Citrus aurantium (Bitter Orange) Extract and p‐Synephrine
por: Stohs, Sidney J.
Publicado: (2017)

Combined Anti-Adipogenic Effects of Hispidulin and p-Synephrine on 3T3-L1 Adipocytes
por: Lee, Dahae, et al.
Publicado: (2021)

An Approach for Identifiability of Population Pharmacokinetic–Pharmacodynamic Models
por: Shivva, V, et al.
Publicado: (2013)

A review of pharmacokinetic and pharmacodynamic interactions with antipsychotics
por: Wijesinghe, Ruki
Publicado: (2016)

Pharmacodynamic Parameters of Pharmacokinetic/Pharmacodynamic (PK/PD) Integration Models
por: Zhang, Longfei, et al.
Publicado: (2022)

Preparation and Crystallographic Analysis of Gliclazide Polymorphs
por: Rajamma, A. J., et al.
Publicado: (2015)

Pharmacokinetics, Pharmacodynamics and Population Pharmacokinetic/Pharmacodynamic Modelling of Bilastine, a Second-Generation Antihistamine, in Healthy Japanese Subjects
por: Togawa, Michinori, et al.
Publicado: (2016)

Biological and Phytopharmacological Descriptions of Litchi Chinensis
por: Kilari, Eswar Kumar, et al.
Publicado: (2016)

Pharmacodynamic and Pharmacokinetic Interactions of Propranolol with Garlic (Allium sativum) in Rats
por: Asdaq, Syed Mohammed Basheeruddin, et al.
Publicado: (2011)

Pharmacokinetic and pharmacodynamic interaction of Rosuvastatin calcium with guggulipid extract in rats
por: Asad, Mohammed, et al.
Publicado: (2021)

Safety and efficacy of a pre-wrkout dietary supplement with and without synephrine
por: Dalton, R, et al.
Publicado: (2015)

Effect of Gliclazide or Gliclazide plus Metformin Combination on Glycemic Control in Patients with T2DM in India: A Real-World, Retrospective, Longitudinal, Observational Study from Electronic Medical Records
por: Polavarapu, Nareen Krishna, et al.
Publicado: (2020)

Pharmacokinetic and pharmacodynamic drug interactions of carbamazepine and glibenclamide in healthy albino Wistar rats
por: Prashanth, S., et al.
Publicado: (2011)

Fractional dynamics pharmacokinetics–pharmacodynamic models
por: Verotta, Davide
Publicado: (2010)

Oxycodone-Related Deaths: The Significance of Pharmacokinetic and Pharmacodynamic Drug Interactions
por: Jakobsson, Gerd, et al.
Publicado: (2022)

Effects of Citrus aurantium (Bitter Orange) Fruit Extracts and p-Synephrine on Metabolic Fluxes in the Rat Liver
por: Peixoto, Jéssica Sereno, et al.
Publicado: (2012)

Effect of p-Synephrine on Fat Oxidation Rate during Exercise of Increasing Intensity in Healthy Active Women
por: Gutiérrez-Hellín, Jorge, et al.
Publicado: (2022)

Nonclinical analysis of the safety, pharmacodynamics, and pharmacokinetics of plasma‐derived human FXIII concentrate in animals
por: Beyerle, Andrea, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_d45mbqh11snfs8203kk1gm8buq